Basis swap and AT1 impact Q4 2025

DNB Group will recognise positive mark-to-market gains in Q4 2025 totaling NOK 331 million, comprising NOK 83 million from basis swaps related to funding and NOK 248 million from USD and SEK Additional Tier 1 (AT1) capital. These items will be reported under Net gains on financial instruments at fair value, providing a one-off uplift to Q4 reported results but reflecting valuation effects rather than recurring operating income.

Analysis

Market structure: The announcement is an idiosyncratic positive for DNB (recognising NOK 83m from basis swaps and NOK 248m from USD/SEK AT1 revals in Q4 2025) and will mechanically lift reported net gains and CET1 optics for that quarter; direct winners are DNB.OL and other Nordic banks with USD/SEK AT1 holdings, while swap counterparties and short sellers of these banks face mark-to-market losses. Funding-cost signalling is important — a materially positive basis move implies either improved NOK funding or tighter cross-currency spreads, which should compress senior and AT1 spreads by ~10–30bp if sustained over 3–6 months. Cross-asset: expect mild NOK/SEK appreciation vs USD, tighter European bank AT1 and senior spreads, and a drop in implied vols for Nordic bank equities in the near term.

Risk assessment: Key tail risks include a reversal of basis moves (>50% reversal would wipe most of the MTM benefit), regulatory changes to AT1 accounting/eligibility, or an idiosyncratic funding shock that widens spreads; any of these could turn a book gain into volatility in a single quarter. Immediate (days) impact is sentiment-driven re-rating; short-term (weeks–months) depends on published Q4 guidance and basis curve persistence; longer-term (quarters) depends on whether funding cost improvement is structural. Hidden dependency: gains are non-cash MTM and do not equal recurring income — capital allocation (dividend/buyback) could mislead investors.

Trade implications: Tactical: establish a 2–3% long position in DNB.OL by end-H2 2025 to capture the Q4 2025 recognition, hedge with a 1–1 notional short in STOXX Europe 600 Banks (SXXP) to isolate Nordic funding alpha; set a stop-loss at -8% or on a >50% reversal in basis curve. Options: buy Jan-2026 DNB 0.30–0.40-delta call spreads sized to 1–2% portfolio risk to cap premium while keeping upside; FX: establish a modest 6–12m short USD/NOK forward sized at 0.5–1% NAV to express NOK squeeze. Monitor basis swap curve and AT1 secondary yields daily; exit if AT1 spreads tighten by >30bp vs peers (signal priced in).

Contrarian angles: The market may underweight that the gain is non-recurring — consensus could overly reward EPS upgrade and then punish on any reversal, creating a shortable pop; conversely, investors may underappreciate the signalling effect on systemic funding costs, leaving Nordic bank credit and AT1 mispriced by 10–30bp. Historical parallels: post-basis normalisations (2019–2020) produced short windows of oversized P/L swings without fundamental credit improvement. Unintended consequence: management may repatriate MTM gains into distributions, reducing liquidity buffers ahead of macro stress — avoid levering into this trade beyond 3% exposure without clear capital action disclosure.

Key Decisions for Investors

• Establish a 2–3% long position in DNB.OL by H2 2025 to capture Q4 2025 MTM recognition (NOK 331m total), hedge with an equal-notional short in STOXX Europe 600 Banks (SXXP) to isolate idiosyncratic upside; cut the long if DNB falls >8% or if basis-swap benefit reverses >50% within 30 days.
• Buy Jan-2026 DNB call spreads (target delta 0.30–0.40) sized to 1–2% portfolio risk to leverage upside into Q4 2025 reporting while capping premium; roll or exit after results release if implied vol collapses >40%.
• Take a modest short USD/NOK forward (6–12m, 0.5–1% NAV) to capture expected NOK strength if funding basis improvement persists; unwind if USD/NOK moves against position by 2% or if Norges Bank signals material policy divergence.
• Allocate up to 1% NAV to selective Nordic bank AT1 secondary purchases where yields exceed peers by >50bp (screen for issuer CET1 >13%); avoid new-issue AT1s and exit if AT1 spread convergence reduces yield pickup below 20bp.